At the moment, there are no entries available for display
financial statements
consolidated
statement of
comprehensive income
| For the year ended 31 December | Notes | 2023 (SAR ’000) |
2022 (SAR ’000) |
| Net income for the year | 16,621,159 | 17,150,825 | |
| Other comprehensive income | |||
| Items that will not be reclassified to the consolidated statement of income in subsequent periods: | |||
| – Net change in fair value (FVOCI equity investment) | 17 | (9,369) | (669,175) |
| – Actuarial gain on re–measurement of employees’ end of service benefits liabilities (“EOSB”) |
17,30 | 2,821 | 231,824 |
| – Share in FVOCI from associate | 17 | 18,333 | 1,316 |
| Items that may be reclassified to the consolidated statement of income in subsequent periods: | |||
| – Exchange difference on translating foreign operations | 17 | (42,712) | (38,229) |
| – Net change in fair value of FVOCI Sukuk and Structured products investments |
17 | 307,054 | 5,449 |
| – Cash flow hedge effective portion of change in the fair value | 57,788 | (41,975) | |
| Total other comprehensive income (loss) for the year recognised in shareholders’ equity |
333,915 | (510,790) | |
| Total comprehensive income for the year | 16,955,074 | 16,640,035 |
The accompanying Notes from 1 to 44 form an integral part of these consolidated financial statements.
Chairman
Chief Executive Officer
Chief Financial Officer